Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2014
11/27/2014US20140348754 Method of Delivering Therapeutics and Imaging Agents to the Brain by Nanoparticles that Cross the Blood Brain Barrier
11/27/2014US20140348744 Compositions and methods for regulating cancer-related signaling pathways
11/27/2014US20140348743 Monoclonal antibodies to programmed death 1 (pd-1)
11/25/2014US8897856 Atherosclerosis therapy via delivery and localized heating of micro size particles
11/25/2014US8895777 Compounds and compositions for delivering active agents
11/25/2014US8895759 Intermediates useful in the preparation of maleimide functionalized polymers
11/25/2014US8895756 Bendamustine pharmaceutical compositions
11/25/2014US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same
11/25/2014US8895630 Non-ionic associative thickeners containing alkyl cyclohexylols, formulations containing them and their uses
11/25/2014US8895557 Pharmaceutical formulations of ecteinascidin compounds
11/25/2014US8895542 Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
11/25/2014US8895538 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
11/25/2014US8895537 Compositions and methods for treating cardiovascular diseases
11/25/2014US8895536 Compositions and methods for treating chronic inflammation and inflammatory diseases
11/25/2014US8895518 Cooperative conveyance of basic active principles by amphiphilic acid molecules
11/25/2014US8895516 Modified saccharides, conjugates thereof, and their manufacture
11/25/2014US8895508 Methods for corneal endothelial proliferation using bFGF sustained-release gelatin hydrogel particles
11/25/2014US8895506 Protein stabilization formulations
11/25/2014US8895504 Amylin derivatives
11/25/2014US8895503 Pharmaceutical composition for transnasal administration of peptide hormones or cytokines
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/25/2014US8895281 Method for preparing a site-specific physiologically active polypeptide conjugate
11/25/2014US8895141 Excipient for compressed tablets comprising novel spherical mannitol
11/25/2014US8895087 Composition to enhance the bioavailability of curcumin
11/25/2014US8895076 Liquid composition of cisplatin coordination compound
11/25/2014US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent
11/25/2014US8895069 Drug delivery system using hyaluronic acid-peptide conjugate micelle
11/25/2014US8895062 Surface-layer protein coated microspheres and uses thereof
11/25/2014US8895059 Reduction of cross-linking gelatin in gelatin capsules
11/25/2014US8895053 Testosterone formulations
11/25/2014US8895051 Flavoring systems for pharmaceutical compositions and methods of making such compositions
11/25/2014US8895050 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
11/25/2014US8895049 Extended release biodegradable ocular implants
11/25/2014US8895033 Sustained release formulations using non-aqueous carriers
11/25/2014US8895032 Dendritic nano-antioxidants
11/25/2014US8895024 Multivalent pneumococcal polysaccharide-protein conjugate composition
11/25/2014US8895023 Nanoparticles for providing immune responses against infectious agents
11/25/2014US8895013 Anthracycline-antibody conjugates for cancer therapy
11/25/2014US8894996 Immunoadjuvant composition and use thereof
11/25/2014US8894988 Tamper resistant dosage forms
11/25/2014US8894987 Tamper resistant dosage forms
11/25/2014US8894978 System and method of complimentary day/night children's skin cream compositions
11/20/2014US20140343324 Synthetic matrix for controlled cell ingrowth and tissue regeneration
11/20/2014US20140343159 Formulation of small adrenergic agonist salt forms in organic solvents
11/20/2014US20140343141 Topical composition comprising an ingenol derivative and a surfactant-cosolvent mixture
11/20/2014US20140343125 Oligonucleotides for rna interference and biological applications thereof
11/20/2014US20140343120 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
11/20/2014US20140343105 Novel orally administered dabigatran formulation
11/20/2014US20140343099 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/20/2014US20140343080 Drug-containing implants and methods of use thereof
11/20/2014US20140343060 Aprepitant l-proline solvates - compositions and cocrystals
11/20/2014US20140343027 Edible oils to enhance delivery of orally administered steroids
11/20/2014US20140343025 Pharmaceutical composition
11/20/2014US20140343010 Co-crystals of dapagliflozin
11/20/2014US20140343005 Aqueous compositions comprising arbekacin
11/20/2014US20140342992 Cell-Penetrating Peptides Having a Central Hydrophobic Domain
11/20/2014US20140342985 Polymeric Devices for Controlled Release of Active Agents
11/20/2014US20140342980 Binding-site modified lectins and uses thereof
11/20/2014US20140342004 Functionalized nanoparticles for intracellular delivery of biologically active molecules
11/20/2014US20140342003 Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
11/20/2014US20140342002 Particulate materials
11/20/2014US20140341999 Antitubercular composition and method for producing same
11/20/2014US20140341998 Pharmaceutical composition for inhalation
11/20/2014US20140341995 Conjugate With Target-Finding Ligand and Use Thereof
11/20/2014US20140341983 Smart™ solid oral dosage forms
11/20/2014US20140341980 Method to Enhance an Immune Response of Nucleic Acid Vaccination
11/20/2014US20140341975 Pathogen and substance traps
11/20/2014US20140341968 Intraocular Drug Delivery Systems
11/20/2014US20140341967 Bi-Functional Co-Polymer Use for Ophthalmic and Other Topical and Local Applications
11/20/2014US20140341966 Steroid-containing sustained release intraocular implants and related methods
11/20/2014US20140341930 Systems and Methods for Diminishing Cell Growth and Inducing Selective Killing of Target Cells
11/20/2014US20140341929 Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
11/20/2014US20140341925 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341924 Formulation of human antibodies for treating tnf-alpha associated disorders
11/20/2014US20140341909 Conjugation of biomolecules using diels-alder cycloaddition
11/20/2014US20140341905 Sparc binding scfvs
11/20/2014US20140341902 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
11/20/2014US20140341892 Anti-alpha2 integrin antibodies and their uses
11/20/2014US20140341844 Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer
11/20/2014US20140341842 Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
11/20/2014US20140341809 High-Affinity DMF5 T Cell Receptor (TCR) Variants
11/20/2014US20140341803 Stable nanoemulsions useful in the treatment of cancer
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/20/2014US20140341801 Inactivation of smooth muscle tissue
11/18/2014US8889889 Crosslinked polymers with the crosslinker as therapeutic for sustained release
11/18/2014US8889847 Antibodies and immunoconjugates and uses therefor
11/18/2014US8889838 Removal of serine proteases by treatment with finely divided silicon dioxide
11/18/2014US8889837 Purification of pegylated polypeptides
11/18/2014US8889835 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
11/18/2014US8889831 Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate
11/18/2014US8889791 Thermoresponsive, biodegradable, elastomeric material
11/18/2014US8889745 Fibrous calcium pyrophosphate particles and methods of making and using same
11/18/2014US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies
11/18/2014US8889669 Cytotoxic benzodiazepine derivatives
11/18/2014US8889663 Formulation for oral transmucosal administration of lipid-lowering drugs
11/18/2014US8889659 Pain relief compositions, manufacture and uses
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889657 Nanoparticle PEG modification with H-phosphonates
11/18/2014US8889635 Dendrimer conjugates
11/18/2014US8889631 Disruptors of early/recycling endosomes
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 1712